These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24980913)

  • 1. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.
    Aucamp M; Odendaal R; Liebenberg W; Hamman J
    Drug Dev Ind Pharm; 2015; 41(7):1100-8. PubMed ID: 24980913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Histotoxic Profile of a Novel Azithromycin-Loaded Lipid-Based Nanoformulation.
    Rahman AU; Khan M; Khan MA; Rehman MU; Abdullah ; Ahmed S
    AAPS PharmSciTech; 2024 Jul; 25(6):157. PubMed ID: 38982006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution-mediated crystallization of amorphous azithromycin.
    Stieger N; Joubert A; Liebenberg W
    Pharmazie; 2017 Aug; 72(8):447-448. PubMed ID: 29441902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye.
    Ren T; Lin X; Zhang Q; You D; Liu X; Tao X; Gou J; Zhang Y; Yin T; He H; Tang X
    Mol Pharm; 2018 Nov; 15(11):4862-4871. PubMed ID: 30251864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdisciplinary science and the design of a single-dose antibiotic therapy.
    Curatolo W
    Pharm Res; 2011 Sep; 28(9):2059-71. PubMed ID: 21311957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on rectal administration of azithromycin by suppository for pediatric use.
    Maeda M; Nakano Y; Aoyama T; Matsumoto Y; Fujito H
    Int J Clin Pharmacol Ther; 2016 Apr; 54(4):263-8. PubMed ID: 26833461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy.
    Lo JB; Appel LE; Herbig SM; McCray SB; Thombre AG
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1522-9. PubMed ID: 19929212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum Loaded Amorphous Azithromycin Produced Using the Wetness Impregnation Method with Fractional Steps for Dermal Prophylaxis Against Lyme Disease.
    Jin N; Pyo SM; Keck CM; Müller RH
    Pharmazie; 2019 Jun; 74(6):345-349. PubMed ID: 31138371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor.
    Cui Y; Chiang PC; Choo EF; Boggs J; Rudolph J; Grina J; Wenglowsky S; Ran Y
    Int J Pharm; 2013 Sep; 454(1):241-8. PubMed ID: 23834830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of oral azithromycin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Mitsui M; Araki M; Fujiyoshi M; Ishii A; Watanabe M; Watanabe T; Nasu Y
    J Infect Chemother; 2019 Oct; 25(10):832-834. PubMed ID: 31255523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.